Zitieren

FIGURE 1.

Second-generation antipsychotic use of 0 to 12-year-old children and all users in Finland (2008 to 2015)
Second-generation antipsychotic use of 0 to 12-year-old children and all users in Finland (2008 to 2015)

FIGURE 2.

Duration of second-generation antipsychotic (SGA) medication. Figures in the “all patients” group do not describe the genuine duration of SGA medication because the duration after the endpoint of the follow-up is not known
Duration of second-generation antipsychotic (SGA) medication. Figures in the “all patients” group do not describe the genuine duration of SGA medication because the duration after the endpoint of the follow-up is not known

FIGURE 3.

Physical examination, BMI measurements, and laboratory tests performed during the second-generation antipsychotic treatment
Physical examination, BMI measurements, and laboratory tests performed during the second-generation antipsychotic treatment

Recommendations for monitoring second-generation antipsychotic treatment according to National Institute for Health and Care Excellence (NICE), American Academy of Child and Adolescent Psychiatry (AACAP), and Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) (39,40,42)

Follow-ups
Issued byBaseline1234
NICEWeekly (first 6 weeks)12 weeksEvery 6 months
Growth chart

Includes weight and height

, WHC, RR, pulse, fb-gluc, HbA1c, lipids, prolactin, MD, nutritional status, diet, physical activity
Growth chart, MD, efficacy, side-effectsGrowth chart, MD, RR, pulse, fb-gluc, HbA1c, lipids, prolactin, physical health, efficacy, side effectsGrowth chart, MD, WHC, RR, pulse, fb-gluc, HbA1c, lipids, prolactin, physical health, efficacy, side effects
AACAPRegular intervals
Family history, BMI, WC, RR, pulse, fb-gluc, lipids, MDBMI, RR, pulse, fb-gluc (HbA1c if needed), lipids

If significant weight changes and/or a family history indicating risk

, MD
CAMESA1, 2, 9 months3 months6 months1 year
Growth chart, BMI, WC, RR, NEU, fb-gluc, insulin, lipids, ASAT, ALAT, TSH (with quetiapine), prolactinGrowth chart, BMI, WC, RR, NEUGrowth chart, BMI, WC, RR, NEU, fb-gluc, insulin, lipids, prolactinGrowth chart, BMI, WC, RR, NEU, fb-gluc, insulin, lipids ASAT, ALAT, TSH (with quetiapine)Same as baseline

International Statistical Classification of Diseases and Related Health Problems, 10th Revision, diagnoses of second-generation antipsychotic (SGA)-treated children (n=133)

DiagnosesICD-10 class%
Hyperkinetic disordersF9050
Conduct/mixed conduct and emotional disorderF91-9240
Pervasive developmental disordersF8430
Obsessive compulsive disorderF4213
Disorders of social functioning with onset specific to childhood and adolescence

ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision

F9413
Reaction to severe stress/adjustment disordersF4310
Tic disordersF95  8
Emotional disorder with onset specific to childhoodF93  7
Disorders of psychological developmentF80-82  7
Depressive episodeF32  6
Bipolar affective disorderF31  5
Psychotic disordersF23, F29  5
Mixed specific developmental disordersF83  5
Other mood (affective) disordersF38  5
Phobic and other anxiety disordersF40-41  3
Dissociative (conversion) disordersF44  3
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

Reactive attachment disorder F94.1 (n=5), other childhood disorders of social functioning F94.8 (n=12)

F98  2
Eating disordersF50  1
Unspecified mental retardationF79  1

Family background of the second-generation antipsychotic-treated children

All (%)PDD/DD (%)Non-PDD/DD (%)p
Family status (n=133)<.001
  Biological parents375726
  Parental separation403642
  Foster home18  624
  Other (e.g. adoption)  5  0  8
Number of siblings (n=126)  NS
  None212320
  One384037
  Two or more413643
Mother’s working status (n=133).018
  Working at least part time536845
  Other or not known473255
Father’s working status (n=133)  NS
  Working at least part time576454
  Other or not known433647
Alcohol/drugs (n=83)604471.021
Psychiatric history of first-degree relatives
  Schizophrenia, bipolar disease or other psychosis (n=67)331545.016
  Depression (n=88)676172  NS
  Suicide (n=133)  NS
    Committed  2  2  2
    At least one attempt  7  2  9
Child exposed to violence (n=133)413048.065
  Exposed to domestic violence11  415
  Been object of physical punishment or other domestic violence121312
  Both exposed and been object11  613
  Other kind of violence exposure (e.g. war experiences)  8  6  8
eISSN:
2245-8875
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
Volume Open
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere